School of Medicine
Showing 2,101-2,200 of 13,019 Results
-
Stephanie Cizek
Clinical Associate Professor, Obstetrics & Gynecology
Clinical Associate Professor (By courtesy), PediatricsBioI am a Pediatric and Adolescent Gynecologist, which combines my passion for gynecology with my love of working with children and young adults (and the people who care for them!). My approach to providing care is a collaborative one: my patients are individually unique and special, and their care should be tailored to be the best fit for them.
Prior to joining the Stanford faculty, I completed a fellowship in Pediatric and Adolescent Gynecology, From an academic standpoint, my current research focuses include: Gynecologic care for Oncology Survivors including Onco-Fertility and vulvovaginal graft-versus-host disease; gynecologic care of patients with Anorectal Malformations; Differences of Sex Development, Intersex conditions, and reproductive tract differences; and surgical care in pediatric gynecology. -
Thomas Clandinin
Shooter Family Professor
Current Research and Scholarly InterestsThe Clandinin lab focuses on understanding how neuronal circuits assemble and function to perform specific computations and guide behavior. Taking advantage of a rich armamentarium of genetic tools available in the fruit fly, combined with imaging, physiology and analytical techniques drawn from systems neuroscience, we examine a variety of visual circuits.
-
Daniel Clark, MD, MPH
Clinical Associate Professor, Medicine - Cardiovascular Medicine
Clinical Assistant Professor, Pediatrics - CardiologyBioDr. Clark is a board-certified, fellowship-trained cardiologist with the Adult Congenital Heart Program at Stanford Health Care. He is also a clinical assistant professor with dual appointments in the Division of Cardiovascular Medicine, Department of Medicine and the Division of Cardiology, Department of Pediatrics at Stanford University School of Medicine.
Dr. Clark specializes in the diagnosis and treatment of adult congenital heart disease (ACHD) and the management of congenital and acquired heart disease in children. His clinical focus involves the combined use of cardiac magnetic resonance (CMR) and other imaging techniques to evaluate patients with known or suspected cardiovascular disease. Dr. Clark’s extensive training and experience with these techniques include multiple fellowships in adult cardiology, cardiovascular imaging, and ACHD.
Dr. Clark is currently a co-investigator on multiple research studies. During his fellowship, he received a training grant from the National Institutes of Health enabling evaluation of the ability of CMR to diagnose COVID-19-associated heart inflammation among college athletes. He currently uses CMR to assess heart transplant outcomes in donors positive for hepatitis C virus. Dr. Clark also received a research grant from the Adult Congenital Heart Disease Association supporting a randomized, controlled clinical trial of cardiac rehabilitation among patients with Fontan failure.
Dr. Clark serves as a peer reviewer for multiple prestigious journals, including The New England Journal of Medicine, Circulation, Journal of the American College of Cardiology, and Journal of the American Heart Association (JAHA). He serves on the editorial board for both JAHA and Circulation: Cardiovascular Imaging. He is also a member of numerous professional medical societies, including the American College of Cardiology, the American Heart Association, and the Adult Congenital Heart Association. -
David Clark
Professor of Anesthesiology, Perioperative and Pain Medicine (MSD)
BioMy career is dedicated to improving the safety, effectiveness and availability of pain relief. Both the needs and opportunities in these areas are limitless. I have had the good fortune of working as a clinician, teacher and scientist at Stanford University and the Palo Alto VA hospital for more than two decades.
Much of my time is spent on laboratory, translational and clinical research. In the laboratory, we are pursuing several projects related to the questions of why pain sometimes becomes chronic after injuries and why opioids lose their effectiveness over time. Alterations in endogenous pain control mechanisms and the involvement of the adaptive system of immunity are central to these investigations. We would like to find ways to maximize functional recovery after surgery and other forms of trauma while minimizing the risks of analgesic use. This work involves local, national and international collaborations. Clinical trials work involves establishing the efficacy of novel forms of analgesic therapy as well as the comparative effectiveness of long-established approaches to controlling common forms of pain such as low back pain. This spectrum of pain-related pursuits continues to evolve with the rapid expansion of the field. -
John Clarke
Clinical Professor, Medicine - Gastroenterology & Hepatology
BioDr. John Clarke recently joined the Gastroenterology & Hepatology Division at Stanford University as Director of the Esophageal Program. He previously spent 17 years in Baltimore, including 9 years on the faculty at Johns Hopkins University where he was an Associate Professor and at various times Director of Esophageal Motility, Director of Gastrointestinal Motility, Clinical Director of the Johns Hopkins Center for Neurogastroenterology, and Clinical Director of the Gastroenterology & Hepatology Division at Johns Hopkins Bayview Medical Center.
His career has combined research, education and clinical care. His clinical areas of expertise include achalasia, dysphagia, eosinophilic esophagitis, esophageal dysmotility, gastroesophageal reflux disease, gastroparesis, GI-manifestations of scleroderma and GI dysmotility. While at Johns Hopkins University, he was inducted into The Miller-Coulson Academy for Clinical Excellence, an institutional honor society for master clinicians at the time limited to 50 members across the entire university.
From an education standpoint, he has lectured in over a dozen countries, authored over 25 textbook chapters and serves on the educational affairs committee of the American College of Gastroenterology. He has also won several major teaching awards, including The Johns Hopkins University Alumni Association Award for Excellence in Teaching, given to one faculty member per year in the entire School of Medicine.
His research has focused on optimization and characterization of diagnostic studies to evaluate motility disorders, as well the relationship between therapeutic endoscopic techniques and treatment of motility disorders. He was an investigator on the NIH Gastroparesis Consortium and is also a former recipient of the AGA Don Castell Award. -
Michael F. Clarke, M.D.
Karel H. and Avice N. Beekhuis Professor of Cancer Biology
Current Research and Scholarly InterestsDr. Clarke maintains a laboratory focused on two areas of research: i) the control of self-renewal of normal stem cells and diseases such as cancer and hereditary diseases; and ii) the identification and characterization of cancer stem cells. His laboratory is investigating how perturbations of stem cell regulatory machinery contributes to human disease. In particular, the laboratory is investigating epigenetic regulators of self renewal, the process by which stem cells regenerate themselves.
-
Shoa L. Clarke, MD, PhD
Assistant Professor of Medicine (Stanford Prevention Research Center) and of Pediatrics (Cardiology)
BioDr. Clarke is a preventive cardiologist and a physician-scientist focused on disease prevention. He earned his undergraduate degree in human biology from the Division of Nutritional Sciences at Cornell University before obtaining his MD and PhD (genetics) from Stanford University School of Medicine. He has completed clinical training in internal medicine (Brigham & Women’s Hospital), pediatrics (Boston Children’s Hospital), and cardiovascular medicine (Stanford Hospital), and he is board certified in all three specialties. His research is focused on 1) understanding complex disease genetics in diverse populations, 2) integrating monogenic and polygenic risk with clinical risk, 3) large-scale phenotyping using the electronic health record and medical images. His clinical practice focuses on identifying risk factors for cardiovascular disease with the goal of promoting health and longevity through evidence-based personalized treatment. He is interested in developing family-centric approaches for the treatment of adults and children carrying genetic risk for disease.
-
Stephanie Clarke
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioDr. Stephanie Clarke is a Licensed Clinical Psychologist and Clinical Assistant Professor of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. Dr. Clarke is an expert in the treatment of suicidal and self-harming behavior in adolescents, with additional expertise in evidence-based treatment of trauma and restrictive eating disorders in adolescents. She is intensively trained in Dialectical Behavior Therapy (DBT), currently the only well-established treatment for self-harming adolescents at high risk for suicide. Dr. Clarke is an Attending Psychologist and supervisor in Stanford’s Adolescent DBT Program, Eating Disorders Clinic, and Comprehensive Care Program (CCP, inpatient unit for medical issues related to disordered eating), where she specialized in seeing complex cases with multiple diagnoses (e.g., comorbid Anorexia Nervosa and suicidality/self-harm). She was the Stanford Psychologist in the DBT Intensive Outpatient Program, RISE, a collaboration between Stanford and Children’s Health Council, where she was in charge of training and supervision of psychology trainees. Dr. Clarke also provides education and training to psychology and psychiatry trainees in DBT, Acceptance and Commitment Therapy (ACT), suicidality, self-harm, mood disorders, eating disorders, and trauma. Dr. Clarke has given numerous talks, trainings, and lectures and has co-authored several publications on the topics of adolescent suicide, self-harming behavior, and DBT.
In 2020, Dr. Clarke was the recipient of the Department of Psychiatry and Behavioral Science's Clinical Innovation and Service Award. Dr. Clarke was also awarded funding from the Professional Leadership Development Awards Program for the 20-21 academic year, which supports the career development of department faculty who exhibit particular promise in advancing into leadership roles in academic medicine. Dr. Clarke has been funded by a grant from the Department of Psychiatry and Behavioral Sciences and the Maternal and Child Health Research Institute to study the safety and feasibility of providing exposure-based trauma treatment to suicidal teens in stage I DBT.
Dr. Clarke also maintains a small private practice, where she provides consultation, parent coaching, and individual therapy for adolescents and adults using DBT, FBT, exposure and response prevention, ACT, compassion-focused, and other CBT and evidence-based approaches. -
Carol Clayberger
Professor (Research) of Pediatrics, Emerita
Current Research and Scholarly InterestsOur group uses molecular biology, biochemistry, and cellular immunology to investigate the activation and effector function of T lymphocytes. Research in the laboratory is currently focused on three areas: granulysin, a lytic molecule expressed late (7-12 days) after T cell activation; identification of correlates of immunity in diseases such as tuberculosis; and tolerance. The long term goal of this work is to develop new ways to treat human disease.
-
Michael Cleary
Lindhard Family Professor of Pediatric Cancer Biology and Professor of Pathology, Emeritus
Current Research and Scholarly InterestsThe role of oncoproteins in cancer and development; molecular and cellular biology of hematologic malignancies; targeted molecular therapies of cancer.
-
William Clusin, MD
Associate Professor of Medicine (Cardiovascular Medicine), Emeritus
Current Research and Scholarly InterestsCardiac action potentials; tissue culture, voltage, clamp technique; role of calcium in ischemia arrhythmias; coronary, artery disease; myocardial infarction.
-
Laetitia Coassolo (Voilquin)
Senior Research Scientist - Basic Life, Pathology Sponsored Projects
Current Role at StanfordI am a Senior Research Scientist in Dr. Katrin Svensson's lab. I am interested in mapping tissue-specific peptide secretion to identify orphan peptide hormones.
-
Ian Coates
Postdoctoral Scholar, Radiology
Trainer, Stanford Nano Shared Facilities Service CenterBioI am a chemical engineer advancing photopolymerization chemistry, fluid mechanics, and materials science to enable fabrication strategies once thought impossible. Pioneered injection Continuous Liquid Interface Production (iCLIP), using active resin chemistry and fluid–optical coupling to achieve order-of-magnitude gains in 3D printing speed and resolution, and translated chemical control of reactive interfaces into free-form microfluidic microneedle systems for intradermal delivery of small molecules, biologics, and mRNA. Current research applies water-soluble biocompatible sacrificial resins and projection-based fabrication workflows to design and print high-resolution, perfusable microvascular architectures for integration into 3D tissue patches.
-
Bernard Mawuli Cobbinah
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
BioCobbinah Bernard Mawuli is a Postdoctoral Scholar at Stanford University in the Department of Anesthesiology, Perioperative and Pain Medicine, School of Medicine. He is passionate about the intersection of AI and medicine, focusing on developing robust and effective approaches for preventive and predictive healthcare. His research aims to deepen the understanding of high-dimensional multi-omics medical data using advanced machine learning techniques. By exploring innovative ways to analyze this data, his work contributes to improved treatments and enhanced patient care. Through the analysis of large patient datasets, his goal is to create tools that empower clinicians to make more informed decisions, ultimately improving healthcare outcomes for all.
Prior to joining Stanford, he pioneered robust federated learning techniques for evolving data streams and developed methods to reduce multi-center MRI variability in diagnosing brain disorders. -
Maria Inmaculada Cobos Sillero
Associate Professor of Pathology
Current Research and Scholarly InterestsOur lab uses cellular and molecular methods, single-cell technology, and quantitative histology to study human neurodegenerative diseases. Current projects include:
- Using single-cell RNA-sequencing to understand selective vulnerability and disease progression in human Alzheimer’s disease brain
- Investigating mechanisms of tau-related neurodegeneration in human brain
- Studying the neocortical and limbic systems in Diffuse Lewy Body Disease (DLBD) at the single cell level -
Jennifer R. Cochran
Vice President for SLAC National Accelerator Laboratory and for Strategic Initiatives, Addie and Al Macovski Professor, Professor of Bioengineering and, by courtesy, of Chemical Engineering
Current Research and Scholarly InterestsMolecular Engineering, Protein Therapeutics, Cancer Therapeutics, Protein Biochemistry, Biotechnology, Cell Engineering, Molecular Imaging, Drug Delivery, Chemical Biology
-
Jeff Codori
Access Services Specialist, School of Medicine - Lane Medical Library
Current Role at StanfordLibrary Specialist, Circulation department, Service Desk.
-
John Coetzee
Social Science Research Scholar, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
BioJohn obtained his BA in Psychology from UC Berkeley, where he worked in a sleep and psychopathology lab. He then worked in a depression lab at UCSF before entering a PhD program at UCLA, where he conducted research on the relationship between language and thought under the guidance of Dr. Martin Monti. After completing his doctorate in Cognitive Neuroscience, he returned to the Bay Area where he currently is a postdoctoral researcher at the Palo Alto VA in the lab of Dr. Maheen Adamson, where he is developing new treatments for traumatic brain injury, and at Stanford in the Brain Stimulation Lab, where he is developing new treatments for depression. His current focus in both labs is on noninvasive neuromodulation.
-
Gwendolyn Coffey
Affiliate, Adult Neurology
BioGwendolyn Coffey, NP is a Nurse Practitioner in Neuro-oncology department at Stanford Health Care.
-
Nathaniel Lee Coggins
Clinical Assistant Professor, Medicine - Primary Care and Population Health
Clinical Assistant Professor, Emergency MedicineBioNathaniel Coggins, M.D. is a palliative care and emergency medicine physician specializing in the implementation and dissemination of palliative care in the emergency department setting. Dr. Coggins holds dual-appointments as Clinical Assistant Professor in the Departments of Medicine and Emergency Medicine and is the Program Director for Stanford Emergency Palliative Care.
Dr. Coggins received his medical degree from the David Geffen School of Medicine at UCLA in 2019, where he was a recipient of the David Geffen Medical Scholarship. He completed his emergency medicine residency training at UCLA and hospice and palliative medicine fellowship training at the University of Utah. Dr. Coggins joined Stanford University as faculty in 2024, where he is an attending physician on the inpatient palliative care service and in the adult emergency department. -
Harvey Cohen
Deborah E. Addicott - John A. Kriewall and Elizabeth A. Haehl Family Professor of Pediatrics, Emeritus
Current Research and Scholarly InterestsMy research interests extend from hypothesis-driven studies in biochemistry and cell biology to discovery-driven interests in proteomics and systems biology to clinical treatment of acute lymphoblastic leukemia of children, and pediatric palliative care.
-
Mitchell B Cohen
Elizabeth Wood Dunlevie Professor and Senior Associate Dean, Maternal and Child Health
BioMitchell B. Cohen, M.D., is a Professor in the Department of Pediatrics in the School of Medicine. He serves as the Chief Medical Officer for Stanford Medicine Children’s Health and the Senior Associate Dean in the School of Medicine for Maternal and Child Health. From 2014-2024, he was the Katharine Reynolds Ireland Chair of Pediatrics at the University of Alabama at Birmingham and the Physician-in-Chief of Children’s of Alabama. Prior to that, he served as the Director of Gastroenterology, Hepatology and Nutrition and Vice Chair of Pediatrics at Cincinnati Children’s Hospital Medical Center.
Dr. Cohen was the founding Director of the P30 Cincinnati Digestive Health Center: Bench to Bedside Research in Pediatric Digestive Diseases His research focused on the mechanism of action of E. coli heat stable enterotoxin, a worldwide cause of infant diarrhea. His laboratory identified that increased guanylyl cyclase (GC-C) receptors for this toxin contributed to the increased susceptibility and severity of diarrhea seen in infants. Identification of the endogenous ligands for GC-C, guanylin and uroguanylin, led to development of knockout mice and an evolving understanding of intestinal secretion and pharmacologic treatment through this ligand-receptor family. Dr. Cohen had a long-standing NIH-supported program of vaccine trials for enteric infection, including a validated human cholera challenge model which resulted in licensure of a cholera vaccine.
Dr. Cohen has held leadership positions in several professional capacities. He served as the only pediatrician on the NIH Commission on Digestive Diseases; he was chair of the Section on Growth, Development and Nutrition of the American Gastroenterological Association (AGA) and the Section on Gastroenterology, Hepatology and Nutrition (SOGHN) of the American Academy of Pediatrics; he was President of NASPGHAN, the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Dr. Cohen was elected to membership in the Association of American Physicians and has received several lifetime achievement awards, including the Shwachman Award from NASPGHAN, the Saul Horowitz Jr. Award from Mt. Sinai, and the UAB Department of Pediatrics Lifetime Achievement Award. -
Sheila E. Cohen
Professor (Clinical) of Anesthesia, Emerita
Current Research and Scholarly InterestsOur obstetric anesthesia group is interested in a variety of topics including the efficacy and mechanism of action of spinal and epidural opioids for production of analgesia during labor, and the functionality of epidural analgesia for labor pain relief.
-
Stanley N. Cohen, MD
Kwoh-Ting Li Professor in the School of Medicine, Professor of Genetics and of Medicine
Current Research and Scholarly InterestsWe study mechanisms that affect the expression and decay of normal and abnormal mRNAs, and also RNA-related mechanisms that regulate microbial antibiotic resistance. A small bioinformatics team within our lab has developed knowledge based systems to aid in investigations of genes.
-
Sara Marie Cohen-Fournier
Adjunct Lecturer, Psych/General Psychiatry and Psychology (Adult)
BioDr. Sara Marie Cohen-Fournier received her undergraduate degree in Science from McGill University, her masters of arts in Oral History from Columbia University, and her medical degree from Université de Montréal. She did her residency in Psychiatry at McGill University and her fellowship in Addiction Medicine at Stanford University. She is currently an adjunct clinical instructor of Addiction Medicine, Stanford University School of Medicine. She practices in rural Northern Quebec, where she works in part at the community center, the Native Friendship Center and at the OUD local clinic. She is interested in under-standing the essence of spirituality, culture, biology, psychology,and society in mental health.
-
Elana Trubowitch Cohn
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Elana Cohn (She/Her) is a board-certified Family Physician, with a love for caring for the whole person and the entire family.
She completed her bachelor's degree in Neuroscience and Behavior at Barnard College, after which she worked as a Health Outreach coordinator on a mobile medical van providing care to the homeless population in NY, which sparked her love for primary care. She received her medical degree at Tel aviv University, and completed her residency at Mount Sinai and the Institute for Family Health.
Her practice spans care for all ages, with an emphasis on care for marginalized populations, reproductive health, office based-procedures, and teaching. She is passionate about integrating mental health care and reproductive justice into general practice, and making care for her patients as comprehensive as possible.
Outside of the office, she loves to travel and explore new places, dance her heart out, and spend time with her family. -
Pasqualina Colella
Affiliate, Pediatrics - Genetics
BioDr. Pasqualina Colella is a scientist with expertise in gene and cell therapy for inherited diseases. She is currently a Senior Research Scientist at Stanford University, where she leads translational research on hematopoietic stem cell transplantation (HSCT), microglia replacement, myeloid cell recruitment to the central nervous system, and genome editing. Her goal is to improve treatment outcomes for neurodegenerative lysosomal storage diseases.
Dr. Colella earned her PhD at TIGEM (Italy), where she developed gene therapies for inherited retinal disorders, including dual AAV approaches for large gene delivery targeting Usher syndrome type 1B and Stargardt disease. During her postdoctoral studies at Genethon (France), she advanced AAV-based gene therapy for Pompe disease, improving efficacy through transgene and promoter engineering. Her work has contributed to several ongoing clinical trials, including those for USH1B and Pompe disease.
Her research has led to more than 30 peer-reviewed publications (16 as first author, 7 as co-corresponding) and 6 patents. She has received awards including the Marie Skłodowska-Curie Fellowship, the Innovative Research Grant from the National MPS Society, and Stanford School of Medicine Shoshana Levy Award to Support Women in Science (Career Development Award). She was also a finalist for the ERC Starting Grant in 2019. -
Todd Coleman
Associate Professor of Bioengineering and, by courtesy, of Electrical Engineering
BioTodd P. Coleman is a Wu Tsai Neurosciences Institute Faculty Scholar and an Associate Professor in the Department of Bioengineering, and by courtesy, Electrical Engineering at Stanford University. He received B.S. degrees in electrical engineering (summa cum laude), as well as computer engineering (summa cum laude) from the University of Michigan (Go Blue). He received M.S. and Ph.D. degrees from MIT in electrical engineering and computer science. He did postdoctoral studies at MIT and Mass General Hospital in quantitative neuroscience. He previously was a faculty member in the Departments of Electrical & Computer Engineering and Bioengineering at the University of Illinois, Urbana-Champaign, and the University of California, San Diego, respectively. Dr. Coleman’s research is very multi-disciplinary, using tools from applied probability, physiology, and bioelectronics. Examples include, for instance, optimal transport methods in high-dimensional uncertainty quantification and developing technologies and algorithms to monitor and modulate physiology of the nervous systems in the brain and visceral organs. He has served as a Principal Investigator on grants from the NSF, NIH, Department of Defense, and multiple private foundations. Dr. Coleman is an inventor on 10 granted US patents. He has been selected as a Gilbreth Lecturer for the National Academy of Engineering, a TEDMED speaker, and a Fellow of IEEE as well as the American Institute for Medical and Biological Engineering. He recently served as Chair of the National Academies Standing Committee on Biotechnology Capabilities and National Security Needs. He is currently a deputy director of the Wu Tsai Neurosciences Institute at Stanford University.
-
A. Dimitrios Colevas, MD
Professor of Medicine (Oncology) and, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS) and of Radiation Oncology (Radiation Therapy)
Current Research and Scholarly InterestsMulti- modality treatment of Head and Neck Cancer
Phase 1 clinical trials -
Roy Collins, MD, MPH
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Roy Collins, MD is a board-certified psychiatrist and Clinical Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. He serves as an Attending Sports Psychiatrist and conducts mental performance research with the Wu Tsai Human Performance Alliance, supporting athletes across collegiate, professional, and international levels. Dr. Collins is the founder of the nation’s first Sports and Performance Psychiatry Fellowship, a pioneering program that provides advanced training in athlete mental health and performance psychiatry. His work bridges clinical expertise, lived experience, elite athletic background, and a commitment to advancing science in service of mental wellness and human performance.
-
Ruben J Colman, MD, PhD
Assistant Professor of Pediatrics (Gastroenterology)
BioDr. Colman is a pediatric gastroenterologist and physician-scientist with an overarching goal to improve and optimize the quality of care and outcomes for children with inflammatory bowel diseases (IBD) through precision medicine approaches. His interdisciplinary team science research program focuses on making precision medicine clinically actionable through innovative solutions merging clinical pharmacology knowledge with ‘-omics’ discoveries using microbiome and metabolomics signatures. Part of this work includes translating these findings into improved clinical treat-to-target endpoints with immediate noninvasive point-of-care measures such as intestinal ultrasound.
The foundation of his current work originates from his PhD titled ‘Precision Dosing and Personalized Medicine in pediatric IBD’. During his training, Dr. Colman was also an American Gastroenterological Association (AGA) editorial fellow for Gastroenterology and he is actively involved in the committees of several professional societies including the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN), the Crohn’s and Colitis Foundation and the International Bowel UltraSound (IBUS) Group. Dr. Colman is supported by a Career Development K23 Award from the NIH, which focuses on evaluating personalized treatment strategies for children with Crohn's disease, specifically examining microbial and transmural intestinal ultrasound findings. He is also funded by awards of the NASPGHAN Foundation and the Stanford Pediatrics Physician-Scientist Bridge to K Program. -
Craig V. Comiter
Professor of Urology and, by courtesy, of Obstetrics and Gynecology
Current Research and Scholarly InterestsUsing various animal models of bladder outlet obstruction as a representation of human prostatic disease, I am investigating how intervening with pharmacotherapy, neuromodulation, and other novel therapies may help to reverse the adverse changes in the bladder due to the obstruction.
I also am investigating new, minimally invasive treatments for post-prostatectomy urinary incontinence.
I am also investigating the role of neruomodulation in the treatment of chronic pelvic pain and IC. -
Iris Cong
MD Student with Scholarly Concentration in Bioengineering / Surgery, expected graduation Spring 2029
BioIris Cong is an M.D. candidate at Stanford School of Medicine. Prior to joining Stanford, she completed her B.S. studies in Computer Science at UCLA, and a Ph.D. in physics/quantum computing at Harvard. Iris is passionate about the potential applications of emerging technologies to medicine. More information can be found on her personal website at https://iriscong.com.
-
Le Cong
Associate Professor of Pathology (Pathology Research) and of Genetics
Current Research and Scholarly InterestsOur lab develops gene-editing technologies like novel CRISPR systems and large gene insertion techniques for gene and cell therapy. We also leverage these gene-editing tools for single-cell functional screening to probe mechanisms of cancer, immunological, and aging-associated diseases. To accelerate our work, we integrate AI and machine learning to design and evolve therapeutic RNAs/proteins, and build AI-XR co-scientists like LabOS that bridge AI computation and biomedical experimentation.
-
Christos E. Constantinou
Associate Professor of Urology, Emeritus
Current Research and Scholarly InterestsMy main recent interest is the application of Biomedical Engineering approaches for the clinical visualization and characterization of the static and dynamic properties of pelvic floor function. This extends to ultrasound Imaging and image processing, construction of computer models and biomechanics analysis of pelvic floor function. It is envisioned that these considerations are important constituents of the clinical evaluation of patients with lower urinary tract dysfunction and urodynamics.
-
Caitlin Contag
Clinical Scholar, Medicine - Pulmonary, Allergy & Critical Care Medicine
Postdoctoral Scholar, Pulmonary and Critical Care MedicineCurrent Research and Scholarly InterestsEmerging pathogens, high-consequence pathogens, critical care in resource limited settings, early interventions for sepsis, marginalized patient populations, sexually transmitted diseases, planetary health
-
Christopher H. Contag
Professor of Pediatrics (Neonatology), Emeritus
Current Research and Scholarly InterestsWe develop and use the tools of molecular imaging to understand oncogenesis, reveal patterns of cell migration in immunosurveillance, monitor gene expression, visualize stem cell biology, and assess the distribution of pathogens in living animal models of human biology and disease. Biology doesn't occur in "a vacuum" or on coated plates--it occurs in the living body and that's were we look for biological patterns and responses to insult.
-
Jennifer Conti, MD, MS, MSc
Adjunct Clinical Assistant Professor, Obstetrics & Gynecology - General
Current Research and Scholarly InterestsClinical decision making around abortion choices; pain management with abortion
-
Simon Conti
Clinical Associate Professor, Urology
BioI am a founding member of the Stanford Urolithiasis Project, where we have studied population health datasets to examine surgical outcomes and environmental risk factors in urinary stone disease. Our current focus includes socioeconomic and ethnic disparities in kidney stone disease, water quality and stone disease, pregnancy in kidney stone disease and geographical variations in kidney stones incidence and metabolic kidney stone work up.
